Paolo Fagone Selected Research

dopachrome isomerase

1/2021	Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
1/2020	Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches.
10/2019	Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma.
10/2019	Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Fagone Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 03/2011
13	Multiple Sclerosis 01/2021 - 06/2013
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2013
6	COVID-19 01/2022 - 07/2020
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 06/2013
5	Inflammation (Inflammations) 01/2021 - 05/2011
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 05/2011
4	Infections 01/2021 - 09/2011
4	Neuroblastoma 03/2020 - 10/2015
4	Melanoma (Melanoma, Malignant) 01/2019 - 08/2012
3	Autoimmune Hepatitis 09/2020 - 11/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 02/2011
2	Cognitive Dysfunction 02/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2020
2	Neuroinflammatory Diseases 07/2021 - 01/2012
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 11/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 11/2019
2	Major Depressive Disorder (Major Depressive Disorders) 05/2020 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019 - 10/2015
2	Rheumatoid Arthritis 11/2019 - 08/2014
2	Glioblastoma (Glioblastoma Multiforme) 09/2018 - 04/2018
2	Parkinson Disease (Parkinson's Disease) 01/2012 - 08/2011
1	Dementia (Dementias) 02/2022
1	Virus Diseases (Viral Diseases) 08/2021
1	Chronic Pain 01/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Discoid Lupus Erythematosus 01/2021
1	Cytokine Release Syndrome 11/2020
1	Autism Spectrum Disorder 10/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2020
1	Fibrosis (Cirrhosis) 09/2020
1	Thromboembolism 09/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2020
1	Disseminated Intravascular Coagulation 09/2020

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2021 - 01/2012
12	Macrophage Migration-Inhibitory FactorsIBA 01/2021 - 08/2011
8	Pharmaceutical PreparationsIBA 01/2021 - 02/2011
7	saquinavir-NOIBA 01/2017 - 02/2011
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2009
4	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2012
4	dopachrome isomeraseIBA 01/2021 - 10/2019
4	DDTIBA 01/2021 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2019
3	Biological ProductsIBA 07/2020 - 09/2018
3	Decitabine FDA Link 11/2019 - 12/2014
3	HIV Protease InhibitorsIBA 01/2017 - 10/2015
3	Saquinavir (Invirase)FDA Link 10/2012 - 02/2011
2	AntioxidantsIBA 02/2022 - 08/2021
2	TOR Serine-Threonine KinasesIBA 01/2022 - 08/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 11/2020
2	Hormones (Hormone)IBA 01/2021 - 02/2011
2	Interleukin-2 (IL2)IBA 01/2021 - 09/2013
2	LipopolysaccharidesIBA 11/2020 - 08/2014
2	Concanavalin AIBA 09/2020 - 01/2018
2	EnzymesIBA 07/2020 - 09/2011
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020 - 09/2019
2	TetraspaninsIBA 01/2020 - 09/2019
2	InterleukinsIBA 12/2019 - 01/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 06/2013
2	sodium boranocarbonateIBA 01/2018 - 04/2015
2	Heme Oxygenase-1IBA 01/2018 - 08/2013
2	AntigensIBA 01/2017 - 12/2012
2	Cyclin D1IBA 10/2015 - 10/2015
2	Acetic Acid (Vinegar)FDA LinkGeneric 08/2014 - 10/2012
2	MTOR InhibitorsIBA 01/2013 - 10/2012
2	Antineoplastic Agents (Antineoplastics)IBA 12/2012 - 08/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2012 - 02/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2012 - 03/2011
2	Protease Inhibitors (Protease Inhibitor)IBA 08/2012 - 02/2011
2	17-triol 7 17-ethynyl-5-androstene-3IBA 01/2012 - 05/2011
1	Neuroprotective AgentsIBA 02/2022
1	Scopolamine (Hyoscine)FDA Link 02/2022
1	Cholinergic Agents (Cholinergics)IBA 02/2022
1	myrtenalIBA 02/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	Thioctic Acid (Lipoic Acid)IBA 08/2021
1	LectinsIBA 07/2021
1	Galectins (Galectin)IBA 07/2021
1	Biological FactorsIBA 01/2021
1	Chemokine CXCL13IBA 01/2021
1	Chemokine CCL5IBA 01/2021
1	DystrophinIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	AntibodiesIBA 01/2021
1	sodium luminolateIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Imatinib Mesylate (Gleevec)FDA Link 09/2020
1	Angiogenesis InhibitorsIBA 09/2020
1	Sorafenib (BAY 43-9006)FDA Link 09/2020
1	Drug CombinationsIBA 09/2020
1	Dacarbazine (DIC)FDA LinkGeneric 09/2020
1	GYY 4137IBA 07/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2020

Therapy/Procedure

8	Therapeutics 07/2020 - 03/2011
2	Immunotherapy 08/2019 - 01/2017
2	Oral Administration 01/2017 - 01/2012